Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining.
about
Histone acetyltransferases: challenges in targeting bi-substrate enzymesPhosphatase complex Pph3/Psy2 is involved in regulation of efficient non-homologous end-joining pathway in the yeast Saccharomyces cerevisiae.Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humansChromatin-regulating proteins as targets for cancer therapy.Epigenetic drugs against cancer: an evolving landscape.Carbon-ion beam irradiation kills X-ray-resistant p53-null cancer cells by inducing mitotic catastropheThe EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Acetylation regulates DNA repair mechanisms in human cells.Role of type II pneumocyte senescence in radiation-induced lung fibrosisMitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin.Chromatin Modulation by Histone Deacetylase Inhibitors: Impact on Cellular Sensitivity to Ionizing Radiation.Garcinol and Its Role in Chronic Diseases.Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.Histone modifications of Notch1 promoter affect lung CD4+ T cell differentiation in asthmatic rats.Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549.
P2860
Q26745642-A32F97F9-6C4D-4C75-B608-99A5997EC3C3Q27938975-A41A1C89-1FF0-4413-9793-115E25D4BE8EQ33798273-2EAA00D7-4114-4F68-9F74-69BEFC7D73CEQ33907067-D301E134-F6B5-4F6B-9F76-6BBABE1AE0FDQ34431964-460EA39B-4E81-4C2A-A5F7-5FE503D6FA0FQ34756947-94771FAD-29BA-4A7D-9F5B-6E0CBBA10599Q35725518-D1B34A6E-BF3D-47CC-BEBF-0B99275550AEQ36197335-9D686F30-3D3A-4EFE-9112-3833C1C07EFDQ37068086-125FE7D6-9F47-403A-A6B2-F168355F6B4CQ37209545-9D28770D-FE16-4CB3-BB4B-A6480A31B052Q37587579-31F06929-EC0A-462C-9BB4-649DA96E4AEFQ37640351-1EB197B9-E973-4DF6-B203-B8240B9926FDQ38965241-CA571B4B-E5FF-42D3-95BA-51E2B9C3AA3FQ39171785-11823898-CFF2-4C63-9030-BBFD2ACDAD74Q42922825-7E1861BD-D9D6-45E6-A64D-3F860E68C713Q50918353-2F6F8EB0-A2CE-482C-BAEE-530745C56C5FQ55116299-7F75AE2F-4CBE-48DE-9EC8-B6EF589CA020
P2860
Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@ast
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@en
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@nl
type
label
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@ast
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@en
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@nl
prefLabel
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@ast
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@en
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@nl
P2093
P1476
Garcinol, a histone acetyltran ...... ng non-homologous end joining.
@en
P2093
Hideaki Ogiwara
Jun Yokota
Kohta Torikai
Takahiro Oike
Takashi Kohno
Takashi Nakano
P304
P356
10.1016/J.IJROBP.2012.01.017
P407
P577
2012-03-13T00:00:00Z